Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CoLucid Pharmaceuticals, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MARINUS PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MARINUS PHARMACEUTICALS, INC.Listing unverified | Buy | $3.4M | conv 40Cluster | SEC | |
MARINUS PHARMACEUTICALS, INC.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MARINUS PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MARINUS PHARMACEUTICALS, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Other | $102.4M | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | Buy | $3M | conv 40Cluster | SEC | |
Tobira Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Tobira Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Ocera Therapeutics, Inc.Listing unverified | Buy | $2M | conv 52ClusterFirst in 12mo | SEC | |
Ocera Therapeutics, Inc.Listing unverified | Buy | $2M | conv 51ClusterFirst in 12mo | SEC | |
ALIMERA SCIENCES INCListing unverified | Sell | $474.2K | SEC | ||
ALIMERA SCIENCES INCListing unverified | Sell | $195.7K | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Sell | $62.4K | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Sell | $59.9K | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Sell | $45.7K | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Sell | $156K | SEC | ||
CADENCE PHARMACEUTICALS INCListing unverified | Sell | $277.4K | SEC |